COVID-19 and lung transplant: controversy and reflection
10.3760/cma.j.cn112434-20200321-00149
- VernacularTitle:COVID-19与肺移植：争议与思考
- Author:
Lei SHEN
1
;
Xiaogang LIU
;
Jie DAI
;
Chang CHEN
;
Gening JIANG
Author Information
1. 同济大学附属上海市肺科医院胸外科 200433
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(7):385-388
- CountryChina
- Language:Chinese
-
Abstract:
Objective:The Corona Virus Disease 2019 (COVID-19), caused by a novel virus (2019-nCoV), is a current epidemic throughout the world. Widespread discussion has been going on about the suitability of lung transplantation for critically-ill patients as an emergent treatment. So far lung transplantation has been performed sporadically in China; however, the relevant treatment and prognosis after transplantation are inconclusive. This article mainly reviews the literature in terms of transplantation and viral infection, indications of lung transplantation, postoperative complications, ethics, and health economics, to elaborate this argument and to further explore the future of lung transplantation for COVID-19.
